WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹173 Cr | ₹109 Cr | ₹64 Cr | ₹67 Cr | ₹160 Cr |
What is the latest Total Debt ratio of WANBURY ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹173 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹67 Cr |
| Mar2021 | ₹160 Cr |
How is Total Debt of WANBURY Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹173 Cr | 58.53 | |
| Mar2024 | ₹109 Cr | 70.37 | |
| Mar2023 | ₹64 Cr | -4.30 | |
| Mar2022 | ₹67 Cr | -58.22 | |
| Mar2021 | ₹160 Cr | - | |
Compare Total Debt of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹736.9 Cr | -1% | -8.3% | -7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -1% |
-8.3% |
-7.8% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses